期刊
JOURNAL OF EXPERIMENTAL MEDICINE
卷 216, 期 5, 页码 1005-1009出版社
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20190609
关键词
-
资金
- Translational Research Institute for Space Health [NNX16AO69A]
With >40 clinical trials underway, we are nearing the first FDA-approved live microbial therapeutic. Here, Giovanni Traverso, MIT and Harvard Medical School Assistant Professor, and colleagues Miguel Jimenez and Institute Professor Robert Langer from MIT discuss the significant challenges of administering live microorganisms to patients and the opportunities for drug delivery of these new complex therapeutics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据